Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Action of cyclic nucleotide phosphodiesterase inhibitors on the acetylcholine potential

  • 17 Accesses

This is a preview of subscription content, log in to check access.

Literature Cited

  1. 1.

    P. D. Brezhestovskii, R. Miledi, and I. Parker, Proc. Roy. Soc. B,211, 15 (1980).

  2. 2.

    L. G. Magazanik, in: Structure and Functions of Biological Membranes [in Russian], Moscow (1975), pp. 240–265.

  3. 3.

    M. A. Poskonova, B. Yu. Kafengauz, and N. E. Babskaya, Dokl. Akad. Nauk SSSR,247, No. 4, 1003 (1979).

  4. 4.

    E. E. Bittar and H. Benjamin, J. Memb. Biol.,39, 57 (1978).

  5. 5.

    A. Eitan and M. Hershkowitz, Eur. J. Pharmacol.,46, 313 (1977).

  6. 6.

    P. Greengard, Science,199, 146 (1978).

  7. 7.

    A. Isaacson, Experientia,25, 1263 (1969).

  8. 8.

    B. Katz and R. Miledi, Nature,226, 962 (1970).

  9. 9.

    B. Katz and R. Miledi, J. Physiol. (London),224, 665 (1972).

  10. 10.

    B. Katz and R. Miledi, Brit. J. Pharmacol.,49, 138 (1973).

  11. 11.

    B. Katz and R. Miledi, Proc. Roy. Soc. B,184, 221 (1973).

Download references

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kafengauz, B.Y., Poskonova, M.A. Action of cyclic nucleotide phosphodiesterase inhibitors on the acetylcholine potential. Bull Exp Biol Med 99, 541–543 (1985). https://doi.org/10.1007/BF00837261

Download citation

Key Words

  • diaphragm muscle
  • acetylcholine potential
  • phosphodiesterase inhibitors
  • blockers of calcium channels